Literature DB >> 23545160

Suppression of cytokine signaling: the SOCS perspective.

Edmond M Linossi1, Jeffrey J Babon, Douglas J Hilton, Sandra E Nicholson.   

Abstract

The discovery of the Suppressor of Cytokine Signaling (SOCS) family of proteins has resulted in a significant body of research dedicated to dissecting their biological functions and the molecular mechanisms by which they achieve potent and specific inhibition of cytokine and growth factor signaling. The Australian contribution to this field has been substantial, with the initial discovery of SOCS1 by Hilton, Starr and colleagues (discovered concurrently by two other groups) and the following work, providing a new perspective on the regulation of JAK/STAT signaling. In this review, we reflect on the critical discoveries that have lead to our current understanding of how SOCS proteins function and discuss what we see as important questions for future research.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine; JAK; Receptor; SOCS; SOCS box

Mesh:

Substances:

Year:  2013        PMID: 23545160      PMCID: PMC3816980          DOI: 10.1016/j.cytogfr.2013.03.005

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  96 in total

Review 1.  Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond.

Authors:  Alfonso Quintás-Cardama; Hagop Kantarjian; Jorge Cortes; Srdan Verstovsek
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

2.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.

Authors:  Peter K K Wong; Paul J Egan; Ben A Croker; Kristy O'Donnell; Natalie A Sims; Sarah Drake; Hiu Kiu; Edward J McManus; Warren S Alexander; Andrew W Roberts; Ian P Wicks
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

4.  Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.

Authors:  R J Rigby; J G Simmons; C J Greenhalgh; W S Alexander; P K Lund
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

5.  SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit.

Authors:  Koh Yamamoto; Mitsuko Yamaguchi; Nobuyuki Miyasaka; Osamu Miura
Journal:  Biochem Biophys Res Commun       Date:  2003-10-31       Impact factor: 3.575

6.  SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis.

Authors:  Ben A Croker; Donald Metcalf; Lorraine Robb; Wei Wei; Sandra Mifsud; Ladina DiRago; Leonie A Cluse; Kate D Sutherland; Lynne Hartley; Emily Williams; Jian-Guo Zhang; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

7.  Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.

Authors:  Christine Brender; Gillian M Tannahill; Brendan J Jenkins; Joel Fletcher; Ruth Columbus; Christiaan J M Saris; Matthias Ernst; Nicos A Nicola; Douglas J Hilton; Warren S Alexander; Robyn Starr
Journal:  Blood       Date:  2007-07-03       Impact factor: 22.113

8.  Mutational switch of an IL-6 response to an interferon-gamma-like response.

Authors:  Ana P Costa-Pereira; Silvia Tininini; Birgit Strobl; Tonino Alonzi; Joerg F Schlaak; Hayaatun Is'harc; Ida Gesualdo; Sally J Newman; Ian M Kerr; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

9.  Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3.

Authors:  Sarah L Dunn; Marie Björnholm; Sarah H Bates; Zhibin Chen; Matthew Seifert; Martin G Myers
Journal:  Mol Endocrinol       Date:  2004-12-16

10.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  74 in total

1.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

Review 2.  SOCS1 and its Potential Clinical Role in Tumor.

Authors:  Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Pathol Oncol Res       Date:  2019-02-13       Impact factor: 3.201

Review 3.  Post-transcriptional regulation of cytokine signaling by AU-rich and GU-rich elements.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

Review 4.  Protein tyrosine phosphatases as wardens of STAT signaling.

Authors:  Frank-D Böhmer; Karlheinz Friedrich
Journal:  JAKSTAT       Date:  2014-02-20

Review 5.  Too much of a good thing: Detrimental effects of interferon.

Authors:  Nancy C Reich
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 6.  Dendritic cells and parasites: from recognition and activation to immune response instruction.

Authors:  Claudia Cristina Motran; Laura Fernanda Ambrosio; Ximena Volpini; Daiana Pamela Celias; Laura Cervi
Journal:  Semin Immunopathol       Date:  2016-09-01       Impact factor: 9.623

7.  Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

Authors:  Carlota Recio; Iolanda Lazaro; Ainhoa Oguiza; Laura Lopez-Sanz; Susana Bernal; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2016-09-08       Impact factor: 10.121

Review 8.  Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer.

Authors:  Marie Muller; Franck Hansmannel; Djesia Arnone; Myriam Choukour; Ndeye Coumba Ndiaye; Tunay Kokten; Rémi Houlgatte; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-04-08       Impact factor: 4.623

9.  Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.

Authors:  Nai-Bin Yang; Shun-Lan Ni; Shan-Shan Li; Sai-Nan Zhang; Dan-Ping Hu; Ming-Qin Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

10.  Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections.

Authors:  Chulbul M Ahmed; Howard M Johnson
Journal:  J Interferon Cytokine Res       Date:  2014-05-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.